Previous close | 33.62 |
Open | 34.73 |
Bid | 32.96 x 300 |
Ask | 33.01 x 300 |
Day's range | 32.81 - 34.83 |
52-week range | 17.53 - 59.84 |
Volume | |
Avg. volume | 911,217 |
Market cap | 2.532B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | N/A |
EPS (TTM) | -7.69 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 28.27 |
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences:
PTC Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript April 25, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]